A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation

NCT04473339 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Epithelial Ovarian Cancer
Ovarian Cancer, Epithelial
Hyperthermic Intraperitoneal Chemotherapy(HIPEC)
Homologous Recombination Repair Gene Mutation

Interventions

PROCEDURE: CRS+HIPEC
PROCEDURE: CRS alone

Sponsor

CAI Hongbing